Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno, Nevada.
Department of Critical Care Medicine, St John's Medical College Hospital, Bengaluru, Karnataka, India.
Am J Cardiol. 2021 May 1;146:29-35. doi: 10.1016/j.amjcard.2021.01.020. Epub 2021 Jan 30.
Anticoagulation alone or in combination with other treatment strategies are implemented to reduce the risk of stroke in patients with atrial fibrillation (AF). Gastrointestinal bleeding (GIB) is a common complication of oral anticoagulation with a prevalence of 1% to 3% in patients on long term oral anticoagulation. We analyzed the national inpatient sample database from the year 2005 to 2015 to report evidence on the frequency, trends, predictors, clinical outcomes, and economic burden of GIB among AF hospitalizations. A total of 34,260,000 AF hospitalizations without GIB and 1,846,259 hospitalizations with GIB (5.39%) were included. The trend of AF hospitalizations with GIB per 100 AF hospitalizations remained stable from the year 2005 to 2015 (p value = 0.0562). AF hospitalizations with GIB had a higher frequency of congestive heart failure, long term kidney disease, long term liver disease, anemia, and alcohol abuse compared with AF hospitalizations without GIB. AF hospitalizations with GIB had a higher odds of in-hospital mortality (Odds ratio (OR) 1.47; 95% Confidence interval (CI): 1.46 to 1.48, p-value <0.0001), mechanical ventilation (OR 1.69; 95% CI: 1.68 to 1.70, p-value <0.0001), and blood transfusion (OR 7.2; 95% CI: 7.17 to 7.22, P-value <0.0001) compared with AF hospitalizations without GIB. AF hospitalizations with GIB had a lower odds of stroke (OR 0.51; 95% CI: 0.51 to 0.52, p-value <0.0001) compared with AF hospitalizations without GIB. Further, AF hospitalizations with GIB had a higher median length of stay and cost of hospitalization compared with AF hospitalizations without GIB. In conclusion, the frequency of GIB is 5.4% in AF hospitalizations and the frequency of GIB remained stable in the last decade as shown in this analysis. When GIB occurs, it is associated with higher resource utilization. This study addresses a significant knowledge gap highlighting national temporal trends of GIB and associated outcomes in AF hospitalizations.
抗凝治疗或联合其他治疗策略被用于降低房颤(AF)患者发生中风的风险。胃肠道出血(GIB)是口服抗凝治疗的常见并发症,在长期口服抗凝治疗的患者中,其发生率为 1%至 3%。我们分析了 2005 年至 2015 年国家住院患者样本数据库,以报告 AF 住院患者中 GIB 的频率、趋势、预测因素、临床结局和经济负担方面的证据。共纳入 3426 万例无 GIB 的 AF 住院患者和 184.6259 例有 GIB(5.39%)的住院患者。从 2005 年到 2015 年,每 100 例 AF 住院患者中发生 GIB 的趋势保持稳定(p 值=0.0562)。与无 GIB 的 AF 住院患者相比,有 GIB 的 AF 住院患者更常伴有充血性心力衰竭、长期肾脏疾病、长期肝脏疾病、贫血和酗酒。有 GIB 的 AF 住院患者院内死亡率(比值比[OR]1.47;95%置信区间[CI]:1.46 至 1.48,p 值<0.0001)、机械通气(OR 1.69;95% CI:1.68 至 1.70,p 值<0.0001)和输血(OR 7.2;95% CI:7.17 至 7.22,p 值<0.0001)的可能性更高。与无 GIB 的 AF 住院患者相比,有 GIB 的 AF 住院患者发生中风的可能性更低(OR 0.51;95% CI:0.51 至 0.52,p 值<0.0001)。此外,有 GIB 的 AF 住院患者的中位住院时间和住院费用均高于无 GIB 的 AF 住院患者。总之,在 AF 住院患者中,GIB 的发生率为 5.4%,在过去十年中,这一分析显示 GIB 的发生率保持稳定。当 GIB 发生时,它与更高的资源利用有关。本研究填补了一个重要的知识空白,强调了 AF 住院患者中 GIB 的全国时间趋势及其相关结局。